Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis

被引：38
|
作者：
Selvaggio, Anna S. [1 ]
Noble, Paul W. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
来源：
ANNUAL REVIEW OF MEDICINE, VOL 67 | 2016年 / 67卷
关键词：
pirfenidone; idiopathic pulmonary fibrosis; interstitial lung disease; Esbriet (R); NECROSIS-FACTOR-ALPHA; OPEN-LABEL; PHASE-3; TRIAL; DOUBLE-BLIND; SURVIVAL; ACETYLCYSTEINE; PROLIFERATION; ACTIVATION; CAPACITY; RECEPTOR;
D O I：
10.1146/annurev-med-120214-013614
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal disease that has long eluded therapy. Prognosis remains very poor, and currently lung transplantation offers the only hope of survival. Recently, great strides have been made in the development of pharmaceutical therapy to treat IPF. Pirfenidone, an oral antifibrotic agent, has been shown to slow progression of the disease and improve progression-free survival, offering new hope for patients suffering from IPF.
引用
收藏
页码：487 / 495
页数：9
相关论文
共 50 条
  • [1] Pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Xaubet, Antoni
    Serrano-Mollar, Anna
    Ancochea, Julio
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) : 275 - 281
  • [2] Pirfenidone treatment of idiopathic pulmonary fibrosis
    Azuma, Arata
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (02) : 107 - 114
  • [3] Pirfenidone treatment of idiopathic pulmonary fibrosis
    Gan, Ye
    Herzog, Erica L.
    Gomer, Richard H.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2011, 7 : 39 - 47
  • [4] Pirfenidone for the treatment of idiopathic pulmonary fibrosis
    George, Peter M.
    Wells, Athol U.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (05) : 483 - 491
  • [5] Pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Poletti, Venerino
    Ravaglia, Claudia
    Tomassetti, Sara
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (05) : 539 - 545
  • [6] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    [J]. SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398
  • [7] The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
    Vincent Cottin
    [J]. Respiratory Research, 14
  • [8] The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
    Cottin, Vincent
    [J]. RESPIRATORY RESEARCH, 2013, 14
  • [9] Pirfenidone in idiopathic pulmonary fibrosis
    Swigris, J.
    Fairclough, D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 695 - 696
  • [10] PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Maher, T. M.
    [J]. DRUGS OF TODAY, 2010, 46 (07) : 473 - 482
12345